# Pegfilgrastim in Patients With Alcoholic Hepatitis

> **NCT02776059** · PHASE2 · COMPLETED · sponsor: **Timothy Morgan, MD** · enrollment: 34 (actual)

## Conditions studied

- Alcoholic Hepatitis

## Interventions

- **DRUG:** Standard of care + pegfiltrastim
- **DRUG:** Standard of care

## Key facts

- **NCT ID:** NCT02776059
- **Lead sponsor:** Timothy Morgan, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-21
- **Primary completion:** 2020-03-31
- **Final completion:** 2021-03-31
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2021-09-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02776059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02776059, "Pegfilgrastim in Patients With Alcoholic Hepatitis". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT02776059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*